The Request for Applications (RFA) Innovation Award is to fund and advance promising innovation that, if successful, would improve the lives of people with type 1 diabetes.

The Innovation Award: Letter of Intent (LOI)  stage was open to the best and brightest researchers, regardless of whether you are currently in the field of type 1 diabetes research or completely new to it. We sought innovative proposals describing cutting-edge innovation falling outside current type 1 diabetes research paradigms supported by collaborative teams.

This award provides project funding of up to $1.5M for a period of two to three years.

What does innovation look like to us?

We have defined innovation as:

    • the generation of a novel idea;
    • extending existing knowledge into a new and distinct area or application;
    • the novel use of research tools or technologies; and/or
    • the novel use of clinical tools, therapies, or strategies;

that addresses a critical barrier and/or will accelerate progress towards preventing, treating or curing type 1 diabetes.

Information sessions

JDRF held Q&A sessions to provide an overview of the goals of this initiative and the application process. If you missed out on attending, please download the slides and the Q&A information sheet. 

 

Important Dates and Deadlines

LOI Application Opens

15

April

2016

 

LOI Application Deadline

22

July

2016

17:00 AEST

Invitation to Full Submission

31

August

2016

 

Full Submission Deadline*

26

October

2016

17:00 AEDT

Interviews

6-7

December

2016

 

Notification to Applicants

 

January

2017

 

 *Applicants must note that the Research Office of each Administering Organisation is required to certify to JDRF all “full submission” applications in RMS360 and may have an internal closing time which precedes this deadline.